Reducing the global burden of tuberculosis: the contribution of improved diagnostics

Emmett Keeler (), Mark D. Perkins, Peter Small, Christy Hanson, Steven Reed, Jane Cunningham, Julia E. Aledort, Lee Hillborne, Maria E. Rafael, Federico Girosi and Christopher Dye
Additional contact information
Emmett Keeler: RAND Corporation
Mark D. Perkins: Foundation for Innovative New Diagnostics
Peter Small: Bill & Melinda Gates Foundation
Christy Hanson: United States Agency for International Development
Steven Reed: Infectious Disease Research Institute
Jane Cunningham: World Health Organization, Avenue Appia
Julia E. Aledort: RAND Corporation
Lee Hillborne: RAND Corporation
Maria E. Rafael: RAND Corporation
Federico Girosi: RAND Corporation
Christopher Dye: World Health Organization, Avenue Appia

Nature, 2006, vol. 444, issue 1, 49-57

Abstract: We estimated the impact of hypothetical new diagnostic tests for tuberculosis (TB) in patients with persistent cough in developing countries. We found that a variety of new tests could help better identify TB cases and target treatment, thereby reducing the burden of disease.

Date: 2006
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.nature.com/articles/nature05446 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:444:y:2006:i:1:d:10.1038_nature05446

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature05446

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().